0001209191-18-049721.txt : 20180905
0001209191-18-049721.hdr.sgml : 20180905
20180905204139
ACCESSION NUMBER: 0001209191-18-049721
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180904
FILED AS OF DATE: 20180905
DATE AS OF CHANGE: 20180905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grigoriadis Dimitri E.
CENTRAL INDEX KEY: 0001423838
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 181056512
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-04
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001423838
Grigoriadis Dimitri E.
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
0
1
0
0
Chief Research Officer
Common Stock
2018-09-04
4
M
0
13632
8.66
A
96574
D
Common Stock
2018-09-04
4
M
0
11037
8.65
A
107611
D
Common Stock
2018-09-04
4
M
0
5978
19.59
A
113589
D
Common Stock
2018-09-04
4
M
0
2102
32.99
A
115691
D
Incentive Stock Option
8.66
2018-09-04
4
M
0
13632
8.66
A
2022-01-12
Common Stock
13632
0
D
Incentive Stock Option
8.65
2018-09-04
4
M
0
11037
8.65
A
2023-01-10
Common Stock
11037
0
D
Incentive Stock Option
19.59
2018-09-04
4
M
0
5978
19.59
A
2024-01-16
Common Stock
5978
0
D
Incentive Stock Option
32.99
2018-09-04
4
M
0
2102
32.99
A
2025-02-03
Common Stock
2102
2710
D
Option granted January 12, 2012 and vested monthly over four years.
Option granted January 10, 2013 and vested monthly over four years.
Option granted January 16, 2014 and vested monthly over four years.
Option granted February 3, 2015 and vests monthly over four years.
/s/ Darin Lippoldt, Attorney-in-Fact
2018-09-05